There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...

The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

For the first time, the FDA completed a generative AI-assisted scientific review pilot, cutting review tasks from days to ...

Food and Drug Administration Director Martin Makary announced the agency-wide deployment of an artificial intelligence tool ...